FERRARI, CAMILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.105
NA - Nord America 5.953
EU - Europa 3.661
SA - Sud America 349
AF - Africa 74
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.187
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.865
HK - Hong Kong 2.632
RU - Federazione Russa 1.522
SG - Singapore 1.236
CN - Cina 1.145
IT - Italia 775
KR - Corea 369
IE - Irlanda 278
PL - Polonia 268
BR - Brasile 261
VN - Vietnam 242
SE - Svezia 190
DE - Germania 178
IN - India 145
FI - Finlandia 119
FR - Francia 102
GB - Regno Unito 81
BD - Bangladesh 70
ID - Indonesia 60
JO - Giordania 54
CA - Canada 48
AU - Australia 43
AR - Argentina 36
AT - Austria 27
JP - Giappone 26
MX - Messico 26
ES - Italia 25
NL - Olanda 24
IQ - Iraq 23
ZA - Sudafrica 18
PK - Pakistan 14
UA - Ucraina 14
NG - Nigeria 13
TR - Turchia 13
BJ - Benin 12
CO - Colombia 12
EC - Ecuador 11
BE - Belgio 10
SA - Arabia Saudita 10
KZ - Kazakistan 9
MA - Marocco 9
PY - Paraguay 9
CH - Svizzera 8
PH - Filippine 8
VE - Venezuela 8
UZ - Uzbekistan 7
GR - Grecia 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
CI - Costa d'Avorio 5
CL - Cile 5
CZ - Repubblica Ceca 5
KE - Kenya 5
TW - Taiwan 5
AZ - Azerbaigian 4
DK - Danimarca 4
NP - Nepal 4
DZ - Algeria 3
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
PA - Panama 3
PE - Perù 3
RS - Serbia 3
UY - Uruguay 3
CR - Costa Rica 2
GE - Georgia 2
IR - Iran 2
JM - Giamaica 2
LB - Libano 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BW - Botswana 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
Totale 16.183
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.566
Santa Clara 1.330
Ashburn 1.009
Singapore 967
Dallas 486
Hefei 397
Seoul 367
Dublin 276
San Jose 273
Warsaw 266
Fairfield 228
Chandler 217
Milan 156
Beijing 135
Woodbridge 122
Council Bluffs 108
Houston 105
Seattle 101
Los Angeles 100
The Dalles 95
Cambridge 85
Buffalo 83
Moscow 82
Altamura 81
Ho Chi Minh City 81
Florence 80
Lawrence 79
Munich 76
Rome 74
New York 71
Wilmington 68
Lauterbourg 66
Mumbai 64
Ann Arbor 58
Kent 55
Jakarta 54
Helsinki 53
Hanoi 51
Princeton 46
Dearborn 43
Melbourne 43
Boston 39
Shanghai 38
Lappeenranta 34
Bremen 33
São Paulo 29
Turku 28
Orem 27
San Diego 26
Bengaluru 22
Boardman 21
Montreal 21
Naples 21
Pune 21
Frankfurt am Main 20
Turin 19
Chicago 18
Medford 18
Nuremberg 18
Tokyo 18
Atlanta 17
Haiphong 17
West Jordan 16
Paris 15
Stockholm 15
Brooklyn 14
Palermo 14
Chennai 13
Clifton 13
Denver 13
San Francisco 13
Abuja 12
Cotonou 12
Vienna 12
Baghdad 11
Ferrara 11
Figino 11
Toronto 11
Brussels 10
Guangzhou 10
London 10
Bari 9
Bologna 9
Johannesburg 9
Manchester 9
Phoenix 9
Falkenstein 8
Poplar 8
Rio de Janeiro 8
Amsterdam 7
Belo Horizonte 7
Da Nang 7
Dhaka 7
Genoa 7
Hải Dương 7
Mexico City 7
Miano 7
New Delhi 7
Yubileyny 7
Amman 6
Totale 11.583
Salva come PNG Salva come JPEG
Nome #
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F-fluorodesoxyglucose-positron emission tomography 2.299
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 400
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 335
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 331
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 256
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 229
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 229
The Games for Older Adults Active Life (GOAL) project for people with mild cognitive impairment and vascular cognitive impairment: A study protocol for a randomized controlled trial 215
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 214
Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes 212
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 200
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 194
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 193
Cognitive functioning among patients with diabetic foot 192
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 191
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 191
Biomarkers study in atypical dementia: proof of a diagnostic work-up 189
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 189
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 188
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 185
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 183
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 182
Primary Progressive Aphasia: Natural History in an Italian Cohort 182
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 182
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 181
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 179
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 179
Intermediate alleles of HTT: A new pathway in longevity 178
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice 176
Cerebrospinal fluid biomarkers for dementia: A case of post-lumbar puncture epidural hematoma 176
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 175
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 175
Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects. 174
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 173
Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia 167
The Frequency of Intermediate Alleles in Patients with Cerebellar Phenotypes 165
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 163
Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease 163
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 161
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 157
Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment 155
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 155
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis 153
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 152
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 151
The diagnosis of dementias: a practical tool not to miss rare causes 151
Parkinson-ALS with a novel MAPT variant 150
The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family 147
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 146
GRN Missense Variants and Familial Alzheimer’s Disease: Two Case Reports 145
The Huntington’s Disease Gene in an Italian Cohort of Patients with Bipolar Disorder 145
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 144
Differential early subcortical involvement in genetic FTD within the GENFI cohort 144
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 143
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 142
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study 141
The complexity of Alzheimer's disease: an evolving puzzle 141
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 139
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 139
Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration 137
Comparing Cerebellar tDCS and Cerebellar tACS in Neurodegenerative Ataxias Using Wearable Sensors: A Randomized, Double-Blind, Sham-Controlled, Triple-Crossover Trial 133
Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia 132
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 128
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 127
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 127
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 125
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 123
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 121
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 118
Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study 115
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 114
Late-onset Huntington disease: An Italian cohort 114
Structural brain splitting is a hallmark of Granulin-related Frontotemporal Dementia 111
Incomplete penetrance in familial Alzheimer’s disease with PSEN1 Ala260Gly mutation 111
No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients 109
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 109
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 107
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 105
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 105
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 95
How can elderly apolipoprotein E ε4 carriers remain free from dementia? 93
Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort 89
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 89
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study 86
Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study 85
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort 85
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 85
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 82
Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia 75
null 63
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia 48
Cerebrovascular Reactivity at Rest and Its Association With Cognitive Function in People With Genetic Frontotemporal Dementia 18
Thalamus involvement in genetic frontotemporal dementia assessed using structural and diffusion MRI: a GENFI study 17
Anatomical progression of genetic frontotemporal lobar degeneration across the lifespan 13
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes 9
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 4
Totale 16.293
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.649
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022315 6 7 17 12 4 24 1 42 13 20 66 103
2022/20231.161 102 233 73 93 66 205 165 56 125 6 23 14
2023/2024910 30 50 76 32 39 84 57 406 23 56 37 20
2024/20254.311 119 434 276 640 1.143 563 61 276 158 135 206 300
2025/20268.435 649 2.899 1.106 477 807 209 643 233 286 376 193 557
2026/20275 5 0 0 0 0 0 0 0 0 0 0 0
Totale 16.293